Staple Line Reinforcement Versus no Reinforcement for Stump Closure in Distal Pancreatectomy: A prospective, single-blinded, randomized controlled trial

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000029147

Enrollment

Unknown

Registered

2020-01-16

Start date

2020-02-03

Completion date

Unknown

Last updated

2020-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic tumors

Interventions

Reinforcement group:Staple line+Suture reinforcement

No Reinforcement group:Staple line

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Surgical candidates for distal pancreatectomy with suspected pancreatic benign or malignant tumors, including: 1. Aged from 18-80 years; 2. Serous or mucinous adenoma; 3. Solid pseudopapillary tumor (SPT); 4. Intraductal papillary mucinous neoplasm (IPMN); 5. Neuroendocrine tumor; 6. Pseudocyst; 7. Distal pancreatic cancer.

Exclusion criteria

Exclusion criteria: 1. Upper abdominal surgical history such as splenectomy, gastrectomy, liver resection, duodenal or pancreatic resection, but not including laparoscopic cystectomy; 2. Pancreatic trauma; 3. Pancreatic eneucleation, central pancreatectomy, pancreaticoduodenectomy; 4. Severe heart or pulmonary diseases not fit for surgeries; 5. Failure in informed consent.

Design outcomes

Primary

Measure	Time frame
Postoperative pancreatic fistula;	—

Countries

China

Contacts

Public ContactJunchao Guo

Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

gjcpumch@163.com+86 13601248088

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026